Exome Asset Management LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 2011932) · Explore on the interactive board
Exome Asset Management LLC disclosed 52 US equity positions worth $162.1m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is GH at 6.2% of the reported book, followed by PRAX, TGTX. The top ten holdings are 44.6% of the book, and the portfolio behaves like about 33 equal-weight positions. Versus the prior filing it opened 15 new positions, added to 1, reduced 32 and exited 8. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Exome Asset Management LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 15 new, 1 added, 32 reduced, 8 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 6.2% | $10.1m | 67,500 | -18% | reduced |
| 2 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 5.6% | $9.1m | 27,205 | -40% | reduced |
| 3 | TGTX TG THERAPEUTICS INC | Healthcare | 5.6% | $9.1m | 164,915 | – | new |
| 4 | COGT COGENT BIOSCIENCES INC | Healthcare | 5.0% | $8.1m | 210,523 | -24% | reduced |
| 5 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 4.3% | $7.0m | 88,177 | -20% | reduced |
| 6 | LLY ELI LILLY & CO | Healthcare | 4.1% | $6.6m | 5,492 | -22% | reduced |
| 7 | ABVX ABIVAX SA | Healthcare | 3.9% | $6.2m | 46,878 | – | new |
| 8 | ALMS ALUMIS INC | Healthcare | 3.5% | $5.8m | 204,418 | -27% | reduced |
| 9 | CYTK CYTOKINETICS INC | Healthcare | 3.2% | $5.1m | 60,056 | -42% | reduced |
| 10 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 3.1% | $5.1m | 100,203 | -54% | reduced |
| 11 | VERA VERA THERAPEUTICS INC | Healthcare | 2.6% | $4.2m | 97,276 | -15% | reduced |
| 12 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.5% | $4.0m | 9,612 | -25% | reduced |
| 13 | TXG 10X GENOMICS INC | Healthcare | 2.4% | $3.9m | 102,629 | -33% | reduced |
| 14 | NTRA NATERA INC | Healthcare | 2.3% | $3.7m | 13,800 | -26% | reduced |
| 15 | UNIQURE NV | 2.3% | $3.7m | 81,056 | – | new | |
| 16 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.2% | $3.6m | 32,209 | -21% | reduced |
| 17 | MAZE MAZE THERAPEUTICS INC | Healthcare | 2.1% | $3.4m | 114,692 | 30% | added |
| 18 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 2.0% | $3.3m | 137,115 | -24% | reduced |
| 19 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 2.0% | $3.2m | 166,493 | -23% | reduced |
| 20 | ALKS ALKERMES PLC | Healthcare | 2.0% | $3.2m | 61,336 | -27% | reduced |
| 21 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.9% | $3.1m | 39,224 | -14% | reduced |
| 22 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.8% | $2.9m | 5,410 | -23% | reduced |
| 23 | GKOS GLAUKOS CORP | Healthcare | 1.7% | $2.8m | 19,862 | -5% | reduced |
| 24 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.6% | $2.6m | 32,214 | -30% | reduced |
| 25 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.6% | $2.6m | 70,500 | -44% | reduced |
| 26 | CBIO CRESCENT BIOPHARMA INC. | 1.4% | $2.3m | 127,769 | -17% | reduced | |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.4% | $2.3m | 12,045 | – | new |
| 28 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.3% | $2.1m | 48,347 | 0% | held |
| 29 | ADAG ADAGENE INC | 1.3% | $2.1m | 488,293 | -34% | reduced | |
| 30 | PEN PENUMBRA INC | Healthcare | 1.2% | $2.0m | 6,300 | 0% | held |
| 31 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.2% | $2.0m | 4,908 | -23% | reduced |
| 32 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.2% | $1.9m | 47,861 | – | new |
| 33 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.1% | $1.8m | 181,588 | – | new |
| 34 | EQ EQUILLIUM INC | 1.1% | $1.8m | 552,956 | – | new | |
| 35 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.1% | $1.8m | 6,573 | – | new |
| 36 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.1% | $1.7m | 184,914 | -21% | reduced |
| 37 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 1.1% | $1.7m | 460,067 | -12% | reduced |
| 38 | VSTM VERASTEM INC | Healthcare | 1.0% | $1.6m | 429,041 | -33% | reduced |
| 39 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.0% | $1.6m | 22,417 | – | new |
| 40 | CLPT CLEARPOINT NEURO INC | 0.9% | $1.5m | 83,636 | – | new | |
| 41 | INSM INSMED INC | Healthcare | 0.9% | $1.5m | 13,873 | -48% | reduced |
| 42 | CAI CARIS LIFE SCIENCES INC | Healthcare | 0.9% | $1.4m | 78,180 | – | new |
| 43 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.8% | $1.4m | 18,359 | -73% | reduced |
| 44 | ZBIO ZENAS BIOPHARMA INC | 0.8% | $1.3m | 52,443 | -35% | reduced | |
| 45 | NBP NOVABRIDGE BIOSCIENCES | Healthcare | 0.7% | $1.1m | 576,960 | 0% | held |
| 46 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.7% | $1.1m | 13,100 | 0% | held |
| 47 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.5% | $889.3k | 47,531 | -83% | reduced |
| 48 | GERN GERON CORP | Healthcare | 0.5% | $798.8k | 624,046 | – | new |
| 49 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.4% | $709.7k | 10,110 | – | new |
| 50 | CMPX COMPASS THERAPEUTICS INC | 0.4% | $604.8k | 276,165 | – | new |
What did Exome Asset Management LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| ELV ELEVANCE HEALTH INC FORMERLY | 26.6% | $4.3m |
| APLSUSD APELLIS PHARMACEUTICALS INC | 21.3% | $3.4m |
| AVTX AVALO THERAPEUTICS INC | 14.7% | $2.4m |
| SLNOEUR SOLENO THERAPEUTICS INC | 12.8% | $2.1m |
| FDMT 4D MOLECULAR THERAPEUTICS IN | 7.5% | $1.2m |
| NXTC NEXTCURE INC | 7.5% | $1.2m |
| PALI PALISADE BIO INC | 6.5% | $1.1m |
| LPCN LIPOCINE INC NEW | 3.0% | $486.3k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 91.8% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Exome Asset Management LLC's portfolio?
Across every quarter Exome Asset Management LLC has filed, its median largest position is 7.4% of the book and its median top-ten weight is 45.5%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 8.0 completed holding spells, the median lasted 1.0 quarters; 52.0 positions are still open and their final length is unknown.